Adel Mekhail - 11 Feb 2025 Form 4 Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Signature
/s/ Adel Mekhail by William P'Pool as attorney-in-fact pursuant to power of attorney dated May 14, 2019 on file with the Commission
Issuer symbol
PBH
Transactions as of
11 Feb 2025
Net transactions value
-$410,336
Form type
4
Filing time
13 Feb 2025, 16:01:19 UTC
Previous filing
14 Nov 2024
Next filing
06 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBH Common Stock, par value $0.01 per share Options Exercise $239,382 +5,400 +29% $44.33 23,765 11 Feb 2025 Direct
transaction PBH Common Stock, par value $0.01 per share Sale $468,828 -5,400 -23% $86.82 18,365 11 Feb 2025 Direct F1
transaction PBH Common Stock, par value $0.01 per share Options Exercise $309,553 +5,683 +31% $54.47 24,048 11 Feb 2025 Direct
transaction PBH Common Stock, par value $0.01 per share Sale $490,443 -5,683 -24% $86.30 18,365 11 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -5,400 -100% $0.000000 0 11 Feb 2025 Common Stock 5,400 $44.33 Direct F3
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -5,683 -67% $0.000000 2,842 11 Feb 2025 Common Stock 5,683 $54.47 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $86.00 to $86.82.
F2 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $86.00 to $86.30.
F3 The options vested in three equal installments of 3,655 shares on May 4, 2021, May 4, 2022 and May 4, 2023.
F4 The options vests in three equal installments of 2,841 shares each on May 2,2023 and 2,842 shares each on May 3, 2024 and May 3, 2025